In October 2014 Bellberry hosted the Crossover conference, an international expert scientific meeting that addressed the challenges of early treatment switching in clinical trial design for oncology.  A further scientific meeting in 2015 allowed for the development and launch of best practice guidelines for trial design and statistical methods from an international expert panel.

Bellberry are pleased to announce the publication of two papers arising from the scientific meetings, which have now been accepted by the International Journal of Technology Assessment in Health Care (Cambridge University Press.)

The first is entitled ‘Treatment Switching: Statistical and Decision Making Challenges and Approaches’  (N. Latimer, C.Henshall, U. Siebert and H. Bell)

The second is entitled ‘Treatment Switching in Cancer Trials: Issues and Proposals’ (N. Latimer, C. Henshall, L.Sansom and R. Ward)